GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

elezanumab   Click here for help

GtoPdb Ligand ID: 9290

Synonyms: ABT-555 | AE12-1Y-QL
Immunopharmacology Ligand
Compound class: Antibody
Comment: Elezanumab (ABT-555) is a fully human monoclonal antibody targeting repulsive guidance molecule-a (RGMA), in development as a potential therapy for multiple sclerosis (MS).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide anaylsis reveals identical matches with peptides claimed in patent WO2013112922 [2].
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
10344 elezanumab
Synonyms Click here for help
ABT-555 | AE12-1Y-QL
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 650
Other databases
GtoPdb PubChem SID 318164809
Search PubMed clinical trials elezanumab
Search PubMed titles elezanumab
Search PubMed titles/abstracts elezanumab